Metabolic Syndrome : Dangerous signs required management
Keywords:
Metabolic Syndrome; Self-management; Behavior modificationAbstract
Metabolic syndrome is a major public health issue in the world including Thailand. This disease increases the risk of developing chronic diseases such as high blood pressure, Type 2 diabetes mellitus, Cardiovascular disease, Chronic kidney disease, and some types of cancer. Metabolic syndrome is a dangerous condition that all public health personnel should be aware of. Health personnel promoting behavior modifications may assist in preventing future chronic diseases.
References
1. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P., et al. The Metabolic Syndrome and Cardiovascular RiskA Systematic Review and Meta-Analysis. J Am Coll Cardiol 2010; 56: 1113-32.
2. Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med 2012; 10: 138- 47.
3. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Amy J, Steig NRS, Pelt REV, et al. The Metabolic Syndrome. Endocr Rev 2008; 29: 777- 822.
4. เทพ หิมะทองคำ, เอกลักษณ์ วโนทยาโรจน์. The Metabolic syndrome กับเวชศาสตร์ครอบครัว. วารสารระบบบริการปฐมภูมิและเวชศาสตร์ครอบครัว 2554; 3: 52- 7.
5. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007; 30: 8-13.
6. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
7. Rezaianzadeh A, Namayandeh SM, Sadr SM. National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease. Int J Prev Med 2012; 3: 552- 8.
8. Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, et al. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes & metabolism. 2008; 57: 980-6.
9. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010; 91: 258S-61S.
10. ปิยะมิตร ศรีธรา,ปริญญ์ วาทีสาธกิจ. Metabolic syndrome ปัจจัยเสี่ยงต่อการเกิดโรคหัวใจในประชากรไทย. CVM 2553; 3: 30-44.
11. Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr 2010; 2: 1. doi: 10.1186/1758-5996-2-1
12. Lyra R, Silva RDS, Junior RMM, Matos MVC, Cezar NJB, Fernandes VO, et al. High prevalence of arterial hypertension in Brazilian Northeast population of low education and income level, ang its association with obesity and metabolic syndrome. Assoc Med 2012; 58: 209-14.
13. Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, Fernández-Labandera C, Cabrera M, Sáinz JC, et al. Occupation-related differences in the prevalence of metabolic syndrome. Diabetes Care 2008; 31: 1884-5.
14. Oh JD, Lee S, Lee JG, Kim YJ, Kim YJ, Cho BM. Health behavior and metabolic syndrome. Korean J Fam Med 2009; 30: 120-8.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–9.
16 Song Q, Wang SS, Zafari AM. Genetics of the Metabolic Syndrome. Hospital Physician. 2006: 51 - 61.
17. ชัยชาญ ดีโรจนวงศ์. Metabolic Syndrome (โรคอ้วนลงพุง). สารราชวิทยาลัยอายุรศาสตร์แห่งประเทศไทย. 2550; 23: 5-17.
18. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006; 95: 136-47.
19. Santos AC, Ebrahim S, Barros H. Gender, socio-economic status and metabolic syndrome in middle-aged and old adults. BMC Public Health 2008; 8: 62-72.
20. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007; 7: 1-8.
21. Nakanishi N, Takatorige T, Suzuki K. Cigarette Smoking and the Risk of the Metabolic Syndrome in Middle-Aged Japanese Male Office Workers. Ind Health 2005; 43 :295-301.
22. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009; 94: 2692-701.
23. Yates T, Davies MJ, Henson J, Troughton J, Edwardson C, Gray LJ, et al. Walking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Fam Pract 2012; 13: 46. doi: 10.1186/1471-2296-13-46.
24. Duvnjak L, Bulum, T, Metelko Z. Hypertension and the Metabolic syndrome. Diabetologia Croatica 2008; 37: 83- 9.
25. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. . American association of clinical endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012; 18 (suppl 1): 1-78.
26. Singh AK, Kari JA. Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2013; 22: 198 - 203.
27. Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, et al. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010; 19: 1737-45.
28. Bo S, Baldi C, Benini L, Dusio F, Forastiere G, Lucia C, et al. Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. J Gen Intern Med 2007; 22: 1695-703.
29. รัชฎา จอปา, จรรจา สันตยากร, นพดล วณิชชากร. ผลของโปรแกรมการจัดการตนเองต่อพฤติกรรมการควบคุมกลุ่มอาการเมตาบอลิกในประชาชนวัยกลางคน. วารสารการพยาบาล และสุขภาพ. 2553; 4: 36-45.
30. วัฒนพล ติ่งซุ่ยกุล, พรชัย จูลเมตต์. ผลของโปรแกรมส่งเสริมการจัดการตนเองต่อพฤติกรรมการบริโภคอาหาร และค่าดัชนีมวลกายของพระภิกษุสูงอายุที่มีภาวะอ้วน. วารสารการพยาบาล และสุขภาพ. 2555; 27: 92-107.
31. Bihan H, Takbou K, Cohen R, Michault A, Boitou F, Reach G, et al. Impact of short-duration lifestyle intervention in collaboration with general practitioners in patients with the metabolic syndrome. Diabetes Metab 2009; 35: 185-91.
32. Powers BJ, Olsen MK, Oddone EZ, Bosworth HB. The Effect of a Hypertension Self-Management Intervention on Diabetes and Cholesterol Control. Am J Med 2009; 122: 639-46.
33. McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, et al. Self-management: Enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin 2011; 61: 50-62.
34. อรวรรณ ประภาศิลป์, ชดช้อย วัฒนะ, ทิพาพร ธาระวานิช. ผลของโปรแกรมการส่งเสริมสมรรถนะในการจัดการตนเองต่อพฤติกรรมการจัดการตนเอง ภาวะอ้วนความเสี่ยงต่อการเกิดโรคหัวใจและหลอดเลือดและการหายจากภาวะเมตาบอลิกซินโดรมในผู้ที่มีภาวะเมตาบอลิกซินโดรม. พยาบาลสาร. 2556; 40: 34-48.
35. Balducci S, Zanuso S, Massarini M, Corigliano G, Nicolucci A, Missori S, et al. The Italian Diabetes and Exercise Study (IDES): design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome. Nutr Metab Cardiovasc Dis 2008; 18: 585-95.
2. Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med 2012; 10: 138- 47.
3. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Amy J, Steig NRS, Pelt REV, et al. The Metabolic Syndrome. Endocr Rev 2008; 29: 777- 822.
4. เทพ หิมะทองคำ, เอกลักษณ์ วโนทยาโรจน์. The Metabolic syndrome กับเวชศาสตร์ครอบครัว. วารสารระบบบริการปฐมภูมิและเวชศาสตร์ครอบครัว 2554; 3: 52- 7.
5. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007; 30: 8-13.
6. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
7. Rezaianzadeh A, Namayandeh SM, Sadr SM. National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease. Int J Prev Med 2012; 3: 552- 8.
8. Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, et al. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes & metabolism. 2008; 57: 980-6.
9. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010; 91: 258S-61S.
10. ปิยะมิตร ศรีธรา,ปริญญ์ วาทีสาธกิจ. Metabolic syndrome ปัจจัยเสี่ยงต่อการเกิดโรคหัวใจในประชากรไทย. CVM 2553; 3: 30-44.
11. Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr 2010; 2: 1. doi: 10.1186/1758-5996-2-1
12. Lyra R, Silva RDS, Junior RMM, Matos MVC, Cezar NJB, Fernandes VO, et al. High prevalence of arterial hypertension in Brazilian Northeast population of low education and income level, ang its association with obesity and metabolic syndrome. Assoc Med 2012; 58: 209-14.
13. Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, Fernández-Labandera C, Cabrera M, Sáinz JC, et al. Occupation-related differences in the prevalence of metabolic syndrome. Diabetes Care 2008; 31: 1884-5.
14. Oh JD, Lee S, Lee JG, Kim YJ, Kim YJ, Cho BM. Health behavior and metabolic syndrome. Korean J Fam Med 2009; 30: 120-8.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–9.
16 Song Q, Wang SS, Zafari AM. Genetics of the Metabolic Syndrome. Hospital Physician. 2006: 51 - 61.
17. ชัยชาญ ดีโรจนวงศ์. Metabolic Syndrome (โรคอ้วนลงพุง). สารราชวิทยาลัยอายุรศาสตร์แห่งประเทศไทย. 2550; 23: 5-17.
18. Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006; 95: 136-47.
19. Santos AC, Ebrahim S, Barros H. Gender, socio-economic status and metabolic syndrome in middle-aged and old adults. BMC Public Health 2008; 8: 62-72.
20. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 2007; 7: 1-8.
21. Nakanishi N, Takatorige T, Suzuki K. Cigarette Smoking and the Risk of the Metabolic Syndrome in Middle-Aged Japanese Male Office Workers. Ind Health 2005; 43 :295-301.
22. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009; 94: 2692-701.
23. Yates T, Davies MJ, Henson J, Troughton J, Edwardson C, Gray LJ, et al. Walking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Fam Pract 2012; 13: 46. doi: 10.1186/1471-2296-13-46.
24. Duvnjak L, Bulum, T, Metelko Z. Hypertension and the Metabolic syndrome. Diabetologia Croatica 2008; 37: 83- 9.
25. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. . American association of clinical endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012; 18 (suppl 1): 1-78.
26. Singh AK, Kari JA. Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2013; 22: 198 - 203.
27. Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, et al. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010; 19: 1737-45.
28. Bo S, Baldi C, Benini L, Dusio F, Forastiere G, Lucia C, et al. Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. J Gen Intern Med 2007; 22: 1695-703.
29. รัชฎา จอปา, จรรจา สันตยากร, นพดล วณิชชากร. ผลของโปรแกรมการจัดการตนเองต่อพฤติกรรมการควบคุมกลุ่มอาการเมตาบอลิกในประชาชนวัยกลางคน. วารสารการพยาบาล และสุขภาพ. 2553; 4: 36-45.
30. วัฒนพล ติ่งซุ่ยกุล, พรชัย จูลเมตต์. ผลของโปรแกรมส่งเสริมการจัดการตนเองต่อพฤติกรรมการบริโภคอาหาร และค่าดัชนีมวลกายของพระภิกษุสูงอายุที่มีภาวะอ้วน. วารสารการพยาบาล และสุขภาพ. 2555; 27: 92-107.
31. Bihan H, Takbou K, Cohen R, Michault A, Boitou F, Reach G, et al. Impact of short-duration lifestyle intervention in collaboration with general practitioners in patients with the metabolic syndrome. Diabetes Metab 2009; 35: 185-91.
32. Powers BJ, Olsen MK, Oddone EZ, Bosworth HB. The Effect of a Hypertension Self-Management Intervention on Diabetes and Cholesterol Control. Am J Med 2009; 122: 639-46.
33. McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, et al. Self-management: Enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin 2011; 61: 50-62.
34. อรวรรณ ประภาศิลป์, ชดช้อย วัฒนะ, ทิพาพร ธาระวานิช. ผลของโปรแกรมการส่งเสริมสมรรถนะในการจัดการตนเองต่อพฤติกรรมการจัดการตนเอง ภาวะอ้วนความเสี่ยงต่อการเกิดโรคหัวใจและหลอดเลือดและการหายจากภาวะเมตาบอลิกซินโดรมในผู้ที่มีภาวะเมตาบอลิกซินโดรม. พยาบาลสาร. 2556; 40: 34-48.
35. Balducci S, Zanuso S, Massarini M, Corigliano G, Nicolucci A, Missori S, et al. The Italian Diabetes and Exercise Study (IDES): design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome. Nutr Metab Cardiovasc Dis 2008; 18: 585-95.
Downloads
Published
2018-06-24
How to Cite
1.
Khamchata L, Dumrongpakapakorn P, Theeranut A. Metabolic Syndrome : Dangerous signs required management. SRIMEDJ [Internet]. 2018 Jun. 24 [cited 2024 Dec. 25];33(4):386-95. Available from: https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/130307
Issue
Section
Review Articles
